2018
DOI: 10.1245/s10434-018-6757-2
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Outcomes for Elderly Gastric Cancer Patients at Least 80 Years of Age Following Gastrectomy in the United States and China

Abstract: Patients ≥ 80 years of age selected for gastrectomy for GC at MSKCC and FMUUH had acceptable morbidity and mortality, and DSS was primarily dependent on TNM stage.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 36 publications
0
6
0
Order By: Relevance
“…Recently, ERAS has been successfully applied to patients with a variety of cancers, including colorectal cancer, bladder cancer and GC[ 28 - 30 ]. Due to preexisting physical injuries or associated comorbidities, elderly patients are more likely to experience higher postoperative complication rates and mortality than relatively healthy and younger patients are[ 31 ]. For ERAS to be implemented in elderly people, surgeons first follow the principle of safety.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, ERAS has been successfully applied to patients with a variety of cancers, including colorectal cancer, bladder cancer and GC[ 28 - 30 ]. Due to preexisting physical injuries or associated comorbidities, elderly patients are more likely to experience higher postoperative complication rates and mortality than relatively healthy and younger patients are[ 31 ]. For ERAS to be implemented in elderly people, surgeons first follow the principle of safety.…”
Section: Discussionmentioning
confidence: 99%
“…Although neoadjuvant therapy is one of the important methods for the treatment of GC, not all patients with GC could benefit from neoadjuvant therapy . Some patients would prefer surgical treatment over neoadjuvant therapy . Additionally, neoadjuvant therapy may affect the depth of tumor invasion, LN metastasis, and surgical outcomes .…”
Section: Discussionmentioning
confidence: 99%
“…33,34 The acceptance of neoadjuvant therapy is relatively low in Eastern countries, with most patients opting for up-front surgery. 35,36 Moreover, considering that neoadjuvant therapy may influence the tumor's infiltration depth, LN metastasis status, and the patient's postoperative outcome, [37][38][39] our study was designed without including patients who received neoadjuvant therapy. This choice was made to better comprehend the worth of splenic hilar lymphadenectomy for patients with APGC, thus providing evidence-based medical substantiation for splenic hilar lymphadenectomy for patients with APGC opting for up-front surgery.…”
Section: Limitationsmentioning
confidence: 99%